This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
L.B. Sheiner, H. Halkin, C. Peck, B. Rosenberg, and K.L. Melmon. Improved computer assisted digoxin therapy: A method using feedback of measured serum digoxin concentrations. Ann. Intern. Med. 82:619–627 (1975).
D. Katz, S.P. Azen, and A. Schumitzky. Bayesian approach to the analysis of nonlinear models: Implementation and evaluation. Biometrics 37:137–142 (1981).
D. Katz, A. Schumitzky, and S.P. Azen. Reduction of dimensionality in Bayesian nonlinear regression with a pharmacokinetic application. Math. Biosci. 59:47–56 (1982).
A. F. M Smith, A.M. Skene, J. E. H. Shaw, J.C. Naylor, and M. Dransfield. The implementation of the Bayesian paradigm. Communications in Statistics, Part A—Theory and Methods 14:1079–1102 (1985).
A.F.M. Smith, A.M. Skene, J. E. H. Shaw, and J.C. Naylor. Progress with numerical and graphical methods for Bayesian statistics. The Statistician 36:75–82 (1987).
D. Katz and D.Z. D’Argenio. Discrete approximation of multivariate densities with application to Bayesian estimation. Computational Statistics & Data Analysis, 2:27–36 (1984).
L. Tierney and J. Kadane. Accurate approximations for posterior moments and marginal densities Journal of the American Statistical Association, 81:82–86 (1986).
R.Y. Rubinstein. Simulation and the Monte Carlo Method. John Wiley, New York, 1981.
B.D. Ripley. Stochastic Simulation. John Wiley, New York, 1987.
J. Geweke. Acceleration methods for Monte Carlo integration in Bayesian inference. Computer Science and Statistics: Proc. of the 20th Symposium on the Interface, 587–592, (1988).
A.F.M. Smith and A.E. Gelfand. Bayesian statistics without tears: A sampling-resampling perspective. The American Statistician 46:84–88 (1992).
M.A. Tanner and W.H. Wong. The calculation of posterior distributions by data augmentation. J. Am. Stat. Assoc. 82:528–540 (1987).
A.E. Gelfand and A.F.M. Smith. Sampling-based approaches to calculating marginal densities. J. Am. Stat. Assoc. 85:398–409 (1990).
C.J. Geyer. Practical Markov chain Monte Carlo (with discussion). Statist. Sci. 7:473–511 (1992).
A.F.M. Smith and G.O. Roberts. Bayesian computation via the Gibbs sampler and related Markov chain Monte Carlo methods. J. Royal Statist. Soc., Series B. 55:3–23, (1993).
L. Tierney. Markov Chains for exploring posterior distributions. Annals of Statist. 22:1701–1762 (1994).
A. Gelman and D.B. Rubin. Practical Markov chain Monte Carlo. Statist. Sci. 7:499–501 (1994).
J.C. Wakefield, A.F.M. Smith, A. Racine-Poon, and A.E. Gelfand. Bayesian analysis of linear and nonlinear population models using Gibbs sampler. Appl. Statist. 41:201–221, (1994).
J.E. Bennett, A. Racine-Poon, and J.C. Wakefield. Markov chain Monte Carlo for nonlinear hierarchical models. In: W.R. Gilks, S. Richardson and D.J. Spiegelhalter, D. J. (eds.), Markov Chain Monte Carlo in Practice, Chapman and Hall, London, 1996, pp. 339–357.
J.C. Wakefield. The Bayesian analysis of population pharmacokinetic models. J. Am. Statist. Assoc. 91:62–75 (1996).
J.C. Wakefield and S.G. Walker. Bayesian nonparametric population models: formulation and comparison with likelihood approaches. J. Pharmacokinet. Biopharm., 25:235–253, (1997).
G.L. Rosner and P. Muller. Bayesian population pharmacokinetic and pharmaco-dynamic analyses using mixture models. J. Pharmacokinet. Biopharm., 25:209–234, (1997).
D. Lunn and L. Aarons. The pharmacokinetics of Saquinavir: a Markov chain Monte Carlo population analysis. J. Pharmacokinet. Biopharm., 26:47–74, (1998).
J.C. Wakefield. An expected loss approach to the design of dosage regimens via sampling. The Statistician. 43:13–29 (1994).
K. Park and D.Z. D’Argenio). Stochastic control of pharmacodynamic processes with application to ergotamine. In: D.Z. D’Argenio (ed.), Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis, Vol. 2, Plenum Press, New York, pp. 189–204, 1995.
J.C. Wakefield. Bayesian individualization via sampling-based methods. J. Pharmacokin. Biopharm. 24:103–131 (1996).
D.Z. D’Argenio and K-S. Park. Uncertain pharmacokinetic/pharmacodynamic systems: Design, estimation and control. Control Eng. Practice, 5:1707–1716 (1997).
K. Park, D. Verotta, S.K. Gupta, and L.B. Sheiner. Use of pharmacokinetic/pharmacodynamic model to design an optimal dose input profile. J. Pharmacokin. Biopharm., 26:471–492 (1998).
P. Mykland, L. Tierney, and B. Yu. Regeneration in Markov chain samplers. J. Amer. Statist. Assoc. 90, 233–241 (1995).
L. Tierney. Introduction to general state-space Markov chain theory. In: W.R. Gilks, S. Richardson and D.J. Spiegelhalter (eds.), Markov Chain Monte Carlo in Practice. Chapman & Hall, London, 1996, pp. 59–74.
E. Nummelin. General Irreducible Markov Chains and Non-negative Operators. Cambridge University Press, Cambridge, U.K., 1984.
M.A. Crane and D.L. Iglehart. Simulating stable stochastic systems, III: Regenerative processes and discrete-event simulations. Oper. Res. 23:33–45 (1975).
D.L. Iglehart. Simulating stable stochastic systems, V: Comparison of ratio estimators. Naval Res. Logistics Quart. 22:553–565 (1975).
D. Kang. Bayesian Inference using Markov Chain Monte Carlo Methods in Pharmacokinetic/Pharmacodynamic Systems Analysis. PhD Dissertation, University of Southern California, Los Angeles, California, 2000.
D.L. Iglehart. Simulating stable stochastic systems, VI: Quantile estimation. J, Assoc. Comput. Mach. 23:347–360 (1976).
J.H. Rodman, M. Abromowitch, J.A. Sinkule, F.A. Hayes, G.K. Rivera, and W.E. Evans. Clinical pharmacodynamics as a determinant of response in a phase I Trial. J. Clin. Oncol. 5:1007–1014 (1987).
P.J. O’Dwyer and I. Slevin. The clinical pharmacology of etoposide and teniposide. Clin. Pharmacokin. 12:223–252 (1987).
J.H. Rodman, W.L. Furman, M. Sunderland, G.K. Rivera, and W.E. Evans. Escalating teniposide systemic exposure to increase dose intensity for pediatric cancer patients. J. Clin. Oncol. 11:287–293 (1993).
D.Z. D’Argenio and J.H. Rodman. Targeting the systemic exposure of teniposide in the population and the individual using a stochastic therapeutic objective. J. Pharmacokin. Biopharm., 21:223–251 (1993).
D. Katz and D.Z. D’Argenio. Discrete approximation of multivariate densities with application to Bayesian inference. Comp. Stat. Data Anal., 2:27–36 (1984).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2004 Kluwer Academic Publishers
About this paper
Cite this paper
Kang, D., Schumitzky, A., D’Argenio, D.Z. (2004). Regenerative Markov Chain Monte Carlo Methods for Pharmacokinetic/Pharmacodynamic Estimation. In: D’Argenio, D.Z. (eds) Advanced Methods of Pharmacokinetic and Pharmacodynamic Systems Analysis Volume 3. The International Series in Engineering and Computer Science, vol 765. Springer, Boston, MA. https://doi.org/10.1007/0-306-48523-0_9
Download citation
DOI: https://doi.org/10.1007/0-306-48523-0_9
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4020-7804-0
Online ISBN: 978-0-306-48523-7
eBook Packages: Springer Book Archive